Skip to Content
Merck
  • Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.

Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.

Journal of molecular medicine (Berlin, Germany) (2011-11-29)
R M Rodriguez, C Huidobro, R G Urdinguio, C Mangas, B Soldevilla, G Domínguez, F Bonilla, A F Fernandez, M F Fraga
ABSTRACT

The bromodomain protein BRD4 is involved in cell proliferation and cell cycle progression, primarily through its role in acetylated chromatin-dependent regulation of transcription at targeted loci. Here, we show that BRD4 is frequently downregulated by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumors. Ectopic re-expression of BRD4 in these colon cancer cell lines markedly reduced in vivo tumor growth, suggesting a role of BRD4 in human colon cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
BRD4 (49-170) His tag human, recombinant, expressed in E. coli, ≥90% (SDS-PAGE)
Sigma-Aldrich
BRD4 (342-460) His tag human, recombinant, expressed in E. coli, ≥90% (SDS-PAGE)
Sigma-Aldrich
BRD4 (342-460) GST tag human, recombinant, expressed in E. coli, ≥75% (SDS-PAGE)
Sigma-Aldrich
BRD4 (49-170) GST tag human, recombinant, expressed in E. coli, ≥82% (SDS-PAGE)
Sigma-Aldrich
BRD4, BD1, BD2 (49-460) His tag human, recombinant, expressed in E. coli, ≥75% (SDS-PAGE)
Sigma-Aldrich
BRD4, BD1, BD2 (49-460) GST tag human, recombinant, expressed in E. coli, ≥80% (SDS-PAGE)